Short interest for {{companyName}} gives investors a sense of the degree to which investors are betting on the decline of {{companyName}}'s stock. Short interest data is updated every two weeks.

General Copper Gold Stock Short Interest Report | OTC:GNRGF | Benzinga

General Copper Gold Corp is an independent mineral exploration company. It is engaged in the business of exploring and evaluating mineral properties. The company is exploring 770 hectares of Clark's Brook gold property in central Newfoundland as well as hectares of Topley Richfield copper-gold property in British Columbia.

GENERAL COPPER GOLD CORP by General Copper Gold Corp.

General Copper Gold Corp

Whales with a lot of money to spend have taken a noticeably bullish stance on Oklo.
Looking at options history for Oklo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>) we detected 35 trades.
If we consider the specifics of each trade, it is accurate to state that 48% of the investors opened trades with bullish expectations and 42% with bearish.
From the overall spotted trades, 20 are puts, for a total amount of $852,722 and 15, calls, for a total amount of $675,968.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $20.0 to $47.0 for Oklo over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Oklo's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Oklo's substantial trades, within a strike price spectrum from $20.0 to $47.0 over the preceding 30 days.
<h3>Oklo Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740772836_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>OKLO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$5.9</td>
<td>$5.65</td>
<td>$5.73</td>
<td>$22.50</td>
<td>$257.8K</td>
<td>979</td>
<td>1.0K</td>
</tr>
<tr>
<td>OKLO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/07/25</td>
<td>$2.26</td>
<td>$2.14</td>
<td>$2.14</td>
<td>$36.00</td>
<td>$85.6K</td>
<td>180</td>
<td>892</td>
</tr>
<tr>
<td>OKLO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$6.3</td>
<td>$5.9</td>
<td>$6.3</td>
<td>$30.00</td>
<td>$62.3K</td>
<td>3.1K</td>
<td>118</td>
</tr>
<tr>
<td>OKLO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$11.9</td>
<td>$11.2</td>
<td>$11.8</td>
<td>$34.00</td>
<td>$59.0K</td>
<td>15</td>
<td>62</td>
</tr>
<tr>
<td>OKLO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$12.15</td>
<td>$11.5</td>
<td>$11.72</td>
<td>$33.00</td>
<td>$58.6K</td>
<td>29</td>
<td>50</td>
</tr>
</tbody>
</table>

<h3>About Oklo</h3>
Oklo Inc is developing advanced fission power plants to provide clean, reliable, and affordable energy at scale. It is pursuing two complementary tracks to address this demand: providing reliable, commercial-scale energy to customers; and selling used nuclear fuel recycling services to the U.S. market. The Company plans to commercialize its liquid metal fast reactor technology with the Aurora powerhouse product line. The first commercial Aurora powerhouse is designed to produce up to 15 megawatts of electricity (MWe) on both recycled nuclear fuel and fresh fuel.
In light of the recent options history for Oklo, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Present Market Standing of Oklo</h3>
<ul>
<li>With a volume of 11,182,131, the price of OKLO is up 2.07% at $33.06. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 11 days.</li>
</ul>
<h3>What The Experts Say On Oklo</h3>
In the last month, 1 experts released ratings on this stock with an average target price of $58.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from B. Riley Securities persists with their Buy rating on Oklo, maintaining a target price of $58. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Oklo with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Options

Markets

OKLO

Oklo's Options: A Look at What the Big Money is Thinking

In the latest quarter, 8 analysts provided ratings for Vertex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERX#NASDAQ">VERX</a>), showcasing a mix of bullish and bearish perspectives.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $51.75, a high estimate of $62.00, and a low estimate of $31.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 10.11%. 
<img src="https://www.benzinga.com/files/images/story/2025/1740772832_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The perception of Vertex by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Samad Samana</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Buy</td>
<td>$48.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>William Jellison</td>
<td>DA Davidson</td>
<td>Lowers</td>
<td>Buy</td>
<td>$55.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Rob Oliver</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$45.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Brad Reback</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$31.00</td>
<td>$58.00</td>
</tr>
<tr>
<td>William Jellison</td>
<td>DA Davidson</td>
<td>Announces</td>
<td>Buy</td>
<td>$62.00</td>
<td>-</td>
</tr>
<tr>
<td>Brad Reback</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$58.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>Steven Enders</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$54.00</td>
<td>$46.00</td>
</tr>
<tr>
<td>Patrick Walravens</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$61.00</td>
<td>$61.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Vertex. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Vertex compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Capture valuable insights into Vertex's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/VERX/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Vertex analyst ratings.</a>
<h2>Delving into Vertex's Background</h2>
Vertex Inc is a provider of tax technology and services. Its software, content, and services help customers stay in compliance with indirect taxes that occur in taxing jurisdictions all over the world. Vertex provides cloud-based and on-premise solutions to specific industries for every line of tax, including income, sales, consumer use, value-added, and payroll. The company offers solutions such as tax determination, Tax Data Management, document management, and compliance and reporting among others. The company derives revenue from software subscriptions.
<h3>Financial Insights: Vertex</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Vertex's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of 17.52%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Information Technology sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Vertex's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 4.24%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Vertex's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 2.93%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of 0.65%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 1.36, caution is advised due to increased financial risk.
<h2>How Are Analyst Ratings Determined?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

VERX

What Analysts Are Saying About Vertex Stock

Natera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTRA#NASDAQ">NTRA</a>) has been analyzed by 9 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">5</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $192.56, a high estimate of $200.00, and a low estimate of $180.00. This current average reflects an increase of 13.44% from the previous average price target of $169.75. 
<img src="https://www.benzinga.com/files/images/story/2025/1740772825_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
A comprehensive examination of how financial experts perceive Natera is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Kyle Mikson</td>
<td>Canaccord Genuity</td>
<td>Raises</td>
<td>Buy</td>
<td>$195.00</td>
<td>$180.00</td>
</tr>
<tr>
<td>Catherine Ramsey</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$188.00</td>
<td>$183.00</td>
</tr>
<tr>
<td>Kyle Mikson</td>
<td>Canaccord Genuity</td>
<td>Maintains</td>
<td>Buy</td>
<td>$180.00</td>
<td>$180.00</td>
</tr>
<tr>
<td>Matthew Sykes</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$190.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Luke Sergott</td>
<td>Barclays</td>
<td>Announces</td>
<td>Overweight</td>
<td>$200.00</td>
<td>-</td>
</tr>
<tr>
<td>Subbu Nambi</td>
<td>Guggenheim</td>
<td>Raises</td>
<td>Buy</td>
<td>$200.00</td>
<td>$170.00</td>
</tr>
<tr>
<td>Eve Burstein</td>
<td>Bernstein</td>
<td>Raises</td>
<td>Outperform</td>
<td>$200.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Kyle Mikson</td>
<td>Canaccord Genuity</td>
<td>Raises</td>
<td>Buy</td>
<td>$180.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>Julia Qin</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$200.00</td>
<td>$160.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Natera. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Natera compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Natera's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
To gain a panoramic view of Natera's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/NTRA/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Natera analyst ratings.</a>
<h2>Delving into Natera's Background</h2>
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
<h3>Natera: A Financial Overview</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Over the 3 months period, Natera showcased positive performance, achieving a revenue growth rate of 63.9% as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Health Care sector.
Net Margin: Natera's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -7.18%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Natera's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of -3.68%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Natera's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -2.03%, the company may face hurdles in achieving optimal financial performance.
Debt Management: Natera's debt-to-equity ratio is below the industry average at 0.54, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>What Are Analyst Ratings?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

NTRA

Deep Dive Into Natera Stock: Analyst Perspectives (9 Ratings)

In the latest quarter, 13 analysts provided ratings for Equitable Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQH#NYSE">EQH</a>), showcasing a mix of bullish and bearish perspectives.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">10</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $61.31, a high estimate of $72.00, and a low estimate of $53.00. Witnessing a positive shift, the current average has risen by 9.0% from the previous average price target of $56.25.
<img src="https://www.benzinga.com/files/images/story/2025/1740772814_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The analysis of recent analyst actions sheds light on the perception of Equitable Holdings by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ryan Krueger</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$66.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Jack Matten</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$72.00</td>
<td>$69.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$62.00</td>
<td>$61.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$61.00</td>
<td>$53.00</td>
</tr>
<tr>
<td>Nigel Dally</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$61.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Ryan Krueger</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$62.00</td>
<td>$58.00</td>
</tr>
<tr>
<td>Mark Hughes</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$60.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>Jack Matten</td>
<td>BMO Capital</td>
<td>Announces</td>
<td>Outperform</td>
<td>$70.00</td>
<td>-</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$53.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Cave Montazeri</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Buy</td>
<td>$58.00</td>
<td>$47.00</td>
</tr>
<tr>
<td>Jimmy Bhullar</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$53.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Alex Scott</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$61.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Ryan Krueger</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$58.00</td>
<td>$54.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Equitable Holdings. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Equitable Holdings compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Equitable Holdings's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
For valuable insights into Equitable Holdings's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/EQH/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Equitable Holdings analyst ratings.</a>
<h2>All You Need to Know About Equitable Holdings</h2>
Equitable Holdings Inc is a financial services company in the U.S. The company provides variable annuities, tax-deferred investment and retirement plans, employee benefits, and protection solutions for individuals, families, and small businesses. Its business segments include Individual Retirement, Group Retirement, Asset Management, Protection Solutions, Wealth Management, and Legacy. It generates the majority of its revenue from the Asset Management segment which provides diversified investment management and related solutions globally to a broad range of clients through three main client channels - Institutional, Retail, and Private Wealth.
<h3>Breaking Down Equitable Holdings's Financial Performance</h3>
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Revenue Growth: Over the 3 months period, Equitable Holdings showcased positive performance, achieving a revenue growth rate of 66.87% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Financials sector.
Net Margin: Equitable Holdings's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 24.11%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Equitable Holdings's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 100.58%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Equitable Holdings's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.29%, the company may face hurdles in achieving optimal financial returns.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 76.27, caution is advised due to increased financial risk.
<h2>The Significance of Analyst Ratings Explained</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Forecasting The Future: 13 Analyst Projections For Equitable Holdings

WIIM

AMPH

Amphastar Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q4 financial results.

LZMH

LZ Technology shares are trading higher following Thursday's IPO.

CDXS

Codexis shares are trading lower after the company reported worse-than-expected Q4 financial results.

As financial markets <a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/02/43955914/market-could-enter-a-real-correction-expert-warns">cooled off in February</a>, investor sentiment spiked downwards near a historic low. However, past bearishness has often amplified returns in the future.
What Happened: The AAII Investor Sentiment Survey found investors particularly <a href="https://www.aaii.com/sentimentsurvey">bearish</a> in the week ending Feb. 26.
Of the investors surveyed, 19.4% had a bullish outlook on the economy, 20% were neutral and 60.6% were bearish. This marks the highest level of bearish sentiment this year, well above the historical average of 31%, and only briefly exceeded in September 2022.
Poor sentiment is likely tied to sticky inflation, possible tariffs from the Trump Administration and a pullback in the artificial intelligence industry.
Why it Matters: According to LPL Financial, markets frequently <a href="https://www.lpl.com/research/blog/investor-sentiment-hits-extremely-bearish-levels.html">overperform</a> following periods of extreme bearishness.
&#8220;&#8230;historically, when the bull-bear spread has been at comparable levels of more than two standard deviations below the average (which has occurred only 4.1% of the time going back to July 1987), S&amp;P 500 returns have been above average,&#8221; a report from LPL&#8217;s George Smith said.
Following &#8220;extremely bearish&#8221; sentiment spreads, the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) has historically returned over 10% within a year, higher than the average return during bullish markets.
LPL Financial also noted the Bank of America Global Fund Manager Survey, which painted a rosier picture of sentiment on Wall Street. Survey respondents are cautiously optimistic, with 82% believing a global recession is unlikely in the next year.
Year-to-date, the S&amp;P 500 is roughly even, following a strong year for the index in 2024. The tech-focused NASDAQ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) has fared worse, shedding 1.78% of its value in 2025.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/25/02/44049626/key-inflation-measure-falls-in-january-should-catch-the-feds-attention-expert-says">Key Inflation Measure Falls In January: &#8216;Should Catch The Fed&#8217;s Attention,&#8217; Economist Says</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Broad U.S. Equity ETFs

Econ #s

Economics

ETFs

Investor Bearishness Surges, Yet Historical Data Suggests Potential Market Gains Ahead

Investors with a lot of money to spend have taken a bullish stance on Victoria's Secret (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSCO#NYSE">VSCO</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with VSCO, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 10 uncommon options trades for Victoria's Secret.
This isn't normal.
The overall sentiment of these big-money traders is split between 70% bullish and 20%, bearish.
Out of all of the special options we uncovered, 5 are puts, for a total amount of $197,472, and 5 are calls, for a total amount of $176,891.
<h3>Projected Price Targets</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $25.0 and $30.0 for Victoria's Secret, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for Victoria's Secret options trades today is 1100.83 with a total volume of 4,589.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Victoria's Secret's big money trades within a strike price range of $25.0 to $30.0 over the last 30 days.
<h3>Victoria's Secret Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740771960_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>VSCO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$4.8</td>
<td>$4.6</td>
<td>$4.65</td>
<td>$30.00</td>
<td>$46.5K</td>
<td>1.0K</td>
<td>402</td>
</tr>
<tr>
<td>VSCO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$4.8</td>
<td>$4.6</td>
<td>$4.64</td>
<td>$30.00</td>
<td>$46.5K</td>
<td>1.0K</td>
<td>720</td>
</tr>
<tr>
<td>VSCO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$4.8</td>
<td>$4.6</td>
<td>$4.65</td>
<td>$30.00</td>
<td>$46.0K</td>
<td>1.0K</td>
<td>820</td>
</tr>
<tr>
<td>VSCO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$2.2</td>
<td>$2.1</td>
<td>$2.2</td>
<td>$27.00</td>
<td>$44.0K</td>
<td>1.6K</td>
<td>1.0K</td>
</tr>
<tr>
<td>VSCO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$3.8</td>
<td>$3.7</td>
<td>$3.7</td>
<td>$25.00</td>
<td>$37.0K</td>
<td>2.6K</td>
<td>100</td>
</tr>
</tbody>
</table>

<h3>About Victoria's Secret</h3>
Victoria's Secret &amp; Co is a specialty retailer of lingerie, pajamas, and beauty products with prestige fragrances and body care. It serves customers at its Lingerie and Beauty stores around the globe and online enabling them to shop the brand anywhere and anytime. The Company operates as a single segment designed to serve customers worldwide seamlessly through stores and online channels.
In light of the recent options history for Victoria's Secret, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Present Market Standing of Victoria's Secret</h3>
<ul>
<li>Trading volume stands at 1,216,267, with VSCO's price down by -1.94%, positioned at $26.35.</li>
<li>RSI indicators show the stock to be may be oversold.</li>
<li>Earnings announcement expected in 5 days.</li>
</ul>
<h3>What The Experts Say On Victoria's Secret</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $36.8.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Telsey Advisory Group persists with their Market Perform rating on Victoria's Secret, maintaining a target price of $40. 
&#x2A; An analyst from Goldman Sachs has decided to maintain their Sell rating on Victoria's Secret, which currently sits at a price target of $35. 
&#x2A; Consistent in their evaluation, an analyst from B of A Securities keeps a Underperform rating on Victoria's Secret with a target price of $35. 
&#x2A; Consistent in their evaluation, an analyst from UBS keeps a Neutral rating on Victoria's Secret with a target price of $34. 
&#x2A; An analyst from Telsey Advisory Group persists with their Market Perform rating on Victoria's Secret, maintaining a target price of $40. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Victoria's Secret, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

VSCO

A Closer Look at Victoria's Secret's Options Market Dynamics

Whales with a lot of money to spend have taken a noticeably bearish stance on Praxis Precision Medicine.
Looking at options history for Praxis Precision Medicine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRAX#NASDAQ">PRAX</a>) we detected 39 trades.
If we consider the specifics of each trade, it is accurate to state that 23% of the investors opened trades with bullish expectations and 69% with bearish.
From the overall spotted trades, 17 are puts, for a total amount of $1,543,653 and 22, calls, for a total amount of $1,277,845.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $30.0 to $115.0 for Praxis Precision Medicine over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Praxis Precision Medicine's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Praxis Precision Medicine's significant trades, within a strike price range of $30.0 to $115.0, over the past month.
<h3>Praxis Precision Medicine Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740771955_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>PRAX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$20.7</td>
<td>$19.2</td>
<td>$20.7</td>
<td>$60.00</td>
<td>$349.8K</td>
<td>5.3K</td>
<td align="right">251</td>
</tr>
<tr>
<td>PRAX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$20.8</td>
<td>$19.2</td>
<td>$20.8</td>
<td>$60.00</td>
<td>$336.9K</td>
<td>5.3K</td>
<td align="right">37</td>
</tr>
<tr>
<td>PRAX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$19.3</td>
<td>$19.2</td>
<td>$19.3</td>
<td>$60.00</td>
<td>$202.6K</td>
<td>5.3K</td>
<td align="right">600</td>
</tr>
<tr>
<td>PRAX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$18.8</td>
<td>$18.1</td>
<td>$18.8</td>
<td>$60.00</td>
<td>$127.8K</td>
<td>5.3K</td>
<td align="right">668</td>
</tr>
<tr>
<td>PRAX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$11.0</td>
<td>$10.6</td>
<td>$11.0</td>
<td>$40.00</td>
<td>$126.5K</td>
<td>1.0K</td>
<td align="right">933</td>
</tr>
</tbody>
</table>

<h3>About Praxis Precision Medicine</h3>
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.
Having examined the options trading patterns of Praxis Precision Medicine, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Present Market Standing of Praxis Precision Medicine</h3>
<ul>
<li>Currently trading with a volume of 2,196,785, the PRAX's price is down by -40.4%, now at $38.76. </li>
<li>RSI readings suggest the stock is currently may be oversold.</li>
<li>Anticipated earnings release is in 11 days.</li>
</ul>
<h3>What Analysts Are Saying About Praxis Precision Medicine</h3>
2 market experts have recently issued ratings for this stock, with a consensus target price of $130.5.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from Needham lowers its rating to Buy with a new price target of $150. 
&#x2A; In a cautious move, an analyst from Deutsche Bank downgraded its rating to Buy, setting a price target of $111. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Praxis Precision Medicine with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

PRAX

Market Whales and Their Recent Bets on PRAX Options

Whales with a lot of money to spend have taken a noticeably bearish stance on Apollo Global Management.
Looking at options history for Apollo Global Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APO#NYSE">APO</a>) we detected 8 trades.
If we consider the specifics of each trade, it is accurate to state that 25% of the investors opened trades with bullish expectations and 75% with bearish.
From the overall spotted trades, 6 are puts, for a total amount of $364,409 and 2, calls, for a total amount of $74,050.
<h3>Expected Price Movements</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $120.0 to $160.0 for Apollo Global Management over the recent three months. 
<h3>Volume &amp; Open Interest Trends</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Apollo Global Management's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Apollo Global Management's substantial trades, within a strike price spectrum from $120.0 to $160.0 over the preceding 30 days.
<h3>Apollo Global Management 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740771950_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>APO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/20/26</td>
<td>$7.7</td>
<td>$7.3</td>
<td>$7.7</td>
<td>$120.00</td>
<td>$100.8K</td>
<td align="right">3</td>
<td align="right">356</td>
</tr>
<tr>
<td>APO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$1.35</td>
<td>$1.15</td>
<td>$1.2</td>
<td>$125.00</td>
<td>$95.6K</td>
<td align="right">10</td>
<td align="right">904</td>
</tr>
<tr>
<td>APO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$9.7</td>
<td>$9.5</td>
<td>$9.7</td>
<td>$130.00</td>
<td>$80.5K</td>
<td align="right">604</td>
<td align="right">1</td>
</tr>
<tr>
<td>APO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$11.2</td>
<td>$10.9</td>
<td>$10.9</td>
<td>$160.00</td>
<td>$49.0K</td>
<td align="right">290</td>
<td align="right">15</td>
</tr>
<tr>
<td>APO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$6.4</td>
<td>$6.3</td>
<td>$6.3</td>
<td>$145.00</td>
<td>$30.8K</td>
<td align="right">543</td>
<td align="right">54</td>
</tr>
</tbody>
</table>

<h3>About Apollo Global Management</h3>
Apollo Global Management Inc is an alternative investment manager. It serves various sectors such as chemicals, manufacturing and industrial, natural resources, consumer and retail, consumer services, business services, financial services, leisure, and media and telecom and technology. The company operates in three business segments that are Asset Management, Retirement Services, and Principal Investing. It generates maximum revenue from the Retirement Services segment.
After a thorough review of the options trading surrounding Apollo Global Management, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Present Market Standing of Apollo Global Management</h3>
<ul>
<li>With a volume of 2,935,331, the price of APO is down -0.19% at $147.16. </li>
<li>RSI indicators hint that the underlying stock may be oversold.</li>
<li>Next earnings are expected to be released in 62 days.</li>
</ul>
<h3>What Analysts Are Saying About Apollo Global Management</h3>
A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $183.67.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Wells Fargo keeps a Overweight rating on Apollo Global Management with a target price of $187. 
&#x2A; An analyst from Morgan Stanley has decided to maintain their Equal-Weight rating on Apollo Global Management, which currently sits at a price target of $170. 
&#x2A; Consistent in their evaluation, an analyst from Keefe, Bruyette &amp; Woods keeps a Outperform rating on Apollo Global Management with a target price of $194. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Apollo Global Management options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Apollo Global Management's Options Frenzy: What You Need to Know

On surface level, satellite and launch service specialist Rocket Lab USA Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) presents itself as a sterling opportunity. For one thing, it's positioned as one of the top players in the burgeoning space economy. On another note, the company is coming off the back of a strong first-quarter sales print. Nevertheless, RKLB stock has been hurting in recent sessions and the pain may worsen.
In isolation, RKLB stock should stand out as an unequivocal sector leader. Following the market close on Thursday, Rocket Lab reported <a href="https://www.benzinga.com/general/space/25/02/44027404/rocket-lab-q4-earnings-revenue-beat-eps-beat-new-satellite-product-multi-launch-agreement-shares-slide-on-soft-guidance">fourth-quarter revenue of $132.39 million</a>, beating the <a href="https://www.benzinga.com/calendars/earnings">consensus estimate</a> of $130.58 million. On the bottom line, the space specialist posted a loss of 10 cents per share, <a href="http://pro.benzinga.com/">in line with expectations</a>.
Additionally, Rocket Lab founder and CEO Peter Beck introduced Flatellite, a <a href="https://www.benzinga.com/general/space/25/02/44034215/rocket-lab-unveils-flatellite-low-cost-mass-producible-satellite-to-target-large-constellations-amid-weak-q1-guidance">low-cost, mass-producible satellite</a> developed by the company for large constellations. This technology will allow enterprises participating in the space economy to facilitate communication among groups of satellites to perform specialized tasks. Further, the innovation has powerful implications for national security, defense and commercial industries.
So, the question of the hour: why is the market response to the earnings report lackluster? The answer lies in the following guidance.
Rocket Lab anticipates that first-quarter revenue will range from $117 million to $123 million. This guidance conspicuously fell short of analysts' consensus view of $135.67 million. Subsequently, the matter drew unwanted attention toward RKLB's sky-high sales <a href="https://finance.yahoo.com/quote/rklb/key-statistics">multiple</a>, which stands at nearly 27 times trailing-12-month (TTM) revenue.
Unfortunately, the problem is that even assuming sales rise to the highest-analyst <a href="https://finance.yahoo.com/quote/RKLB/analysis/">estimate</a> for fiscal 2025 of $649.78 million, RKLB stock would be trading at a sales multiple of over 15 times. In the first calendar quarter last year, RKLB exchanged hands at only 8.1 times revenue. Hence, the disconnect between Rocket Lab's fourth-quarter performance and market sentiment for its equity.
<h2 class="wp-block-heading">Technical And Statistical Risks Also Cloud RKLB Stock</h2>
While Rocket Lab might seem to be a discounted investment, the problem is professional traders must make a distinction between an entity being undervalued versus merely being cheap. This assessment isn't as easy as it sounds, thereby introducing technical risks to RKLB stock. As if to reinforce the point, RKLB doesn't enjoy a statistically robust framework when responding to extreme volatility.
To be sure, the space economy is a massive industry, one which Morgan Stanley predicts <a href="https://www.benzinga.com/news/earnings/24/10/41227346/the-race-for-space-3-small-cap-space-stocks-to-buy">could reach $1 trillion by 2040</a>. However, McKinley &amp; Company issued a reality check — colloquially a truth bomb — against excessive speculation. "Given the capital-intensive <a href="https://www.mckinsey.com/industries/aerospace-and-defense/our-insights/a-different-space-race-raising-capital-and-accelerating-growth-in-space">nature</a> of space products, [venture capitalists] like to see that companies have the proprietary and unique tech to achieve clear differentiation and a strong ‘competitive moat' to prevent future market share erosion," the consulting firm wrote.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="600" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28142701/RKLB-stock-technical-chart-1024x600.jpg" alt="" class="wp-image-804374" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28142701/RKLB-stock-technical-chart-1024x600.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28142701/RKLB-stock-technical-chart-300x176.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28142701/RKLB-stock-technical-chart-768x450.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28142701/RKLB-stock-technical-chart.jpg 1028w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Image by TradingView</figcaption></figure>
By logical deduction, there are significant technical risks against RKLB stock, especially if it cannot quickly and convincingly storm above the psychological threshold of $20. The longer the security lingers sandwiched between its 50-day and 200-day moving averages (at $26.53 and $13.52, respectively), the more the hot sales multiple may induce anxiety among shareholders — especially shareholders who are already deeply profitable (for now).
To emphasize the risks, RKLB stock by nature is a coin flip. Using data since its public market debut, a position entered at the beginning of the week has a 48.1% chance of rising by the end of it. Over an eight-week period, this baseline probability is 50/50.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28141745/RKLB-stock-probability-gambit-1024x576.jpg" alt="" class="wp-image-804356" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28141745/RKLB-stock-probability-gambit-1024x576.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28141745/RKLB-stock-probability-gambit-300x169.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28141745/RKLB-stock-probability-gambit-768x432.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28141745/RKLB-stock-probability-gambit.jpg 1280w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Image by author</figcaption></figure>
When calculating probabilities dynamically — in this case, accounting for severe volatility — pricing behaviors shift unfavorably. Following a one-week loss between 10% and 20%, RKLB historically has a 25% chance of rising in the first subsequent week. Over an eight-week holding period, the likelihood of profitability is only 40%.
For this week, RKLB stock is on pace to lose around 17%. Assuming prevailing winds under similar circumstances materialize, the outlook is more negative than positive.
<h2 class="wp-block-heading">Rocket Lab's Wild Nature Delights Agnostic Traders</h2>
Although Rocket Lab may not be the most comfortable investment based on its wild nature, the framework seems to delight agnostic traders who are looking to extract profits no matter the direction.
In this case, while the probabilities may imply a net negative outcome for RKLB stock, the trajectory will likely not be perfectly linear. Running a guided Monte Carlo simulation reflecting RKLB's probability dynamics reveals the possibility of a dead-cat bounce within the next two weeks before ultimately eroding to around where its 200 DMA currently sits.
With this market intelligence, traders can deploy two different options strategies. First, one could consider a 19/20 bull call spread for the options chain expiring March 14. This transaction involves buying the $19 call (at a $182 ask) and simultaneously selling the $20 call (at a $125 bid). The idea is to front run the potential dead-cat bounce.
Traders use the short call sale to offset some of the long call's debit, resulting in a net debit of $57. The maximum reward should RKLB stock reach $20 at expiration is $43, or a 75.4% payout.
However, the most aggressive trade may be the 18/17 bear put spread for the options chain expiring March 28. This expiration period coincides with when RKLB stock is projected to incur the lowest odds of upside success from the anchor point.
Specifically, the above transaction involves buying the $18 put (at a $116 ask) and simultaneously selling the $17 put (at a $73 bid), resulting in a net debit paid of $43. The maximum reward should RKLB stock drop to $17 is $57 or a 132.6% payout.
For the March 28 expiration, speculators can go less aggressive with a 19/18 bear put spread, although the payout diminishes considerably to 72.4% due to the higher likelihood of success.
Photo: Shutterstock

Earnings

Equities

Short Ideas

RKLB

Options Corner: Traders May Price In A Reality Check For Rocket Lab USA

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>JP Morgan analyst Nick Lai upgraded the rating for Li Auto Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LI#NASDAQ">LI</a>) from Neutral to Overweight and raised the price target from $22 to $40. Li Auto shares closed at $31.92 on Thursday. <a href="https://www.benzinga.com/quote/LI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup analyst Paul Lejuez upgraded Bath &amp; Body Works, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBWI#NYSE">BBWI</a>) from Neutral to Buy and raised the price target from $40 to $48. Bath &amp; Body Works shares closed at $35.86 on Thursday. <a href="https://www.benzinga.com/quote/BBWI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Morgan Stanley analyst Nigel Dally upgraded Voya Financial, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VOYA#NYSE">VOYA</a>) from Equal-Weight to Overweight and raised the price target from $76 to $87. Voya Financial shares closed at $70.50 on Thursday. <a href="https://www.benzinga.com/quote/VOYA/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Piper Sandler analyst Brian Mullan upgraded CAVA Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAVA#NYSE">CAVA</a>) from Neutral to Overweight but lowered the price target from $142 to $115. Cava Group shares closed at $90.08 on Thursday. <a href="https://www.benzinga.com/quote/CAVA/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Loop Capital analyst Alan Gould upgraded Nexstar Media Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXST#NASDAQ">NXST</a>) from Hold to Buy and raised the price target from $190 to $200. Nexstar Media shares closed at $162.58 on Thursday. <a href="https://www.benzinga.com/quote/NXST/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Read This Next:
<ul>
<li> <a href="https://www.benzinga.com/25/02/44018351/top-3-utilities-stocks-you-may-want-to-dump-in-february">Top 3 Utilities Stocks You May Want To Dump In February</a></li>
</ul>

News

Upgrades

Trading Ideas

BBWI

CAVA

NXST

VOYA

This Li Auto Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday

After a dream run-up in share prices over the last several years, 2025 has been a rough ride for the semiconductor sector, with big brand names like Nvidia, Advanced Micro Devices, and Taiwan Semiconductor all in red numbers this year.
"When we look at the semiconductor space right now, we&#8217;ve seen the industry began to recover pretty strongly last year, but a lot of that growth, that recovery was very uneven," said Mario Morales, group vice president of enabling technologies and semiconductors at IDC in San Francisco.
Here&#8217;s why &#8211; and why the bull market in chip stocks may be over, for now.
Additionally, the larger industry names are grappling with supply chain snarls, geopolitical chess games, and the relentless pace of technological evolution. "Meanwhile, the race for AI supremacy has turned into more of an arms race, with companies scrambling to outdo each other in the quest for faster, more efficient chips," said Lars Nyman, chief marketing officer of Portugal-based CUDO Compute. "Production costs soar, and the demand for chips seems to skyrocket like a meme stock. Yes, the thirst for more advanced nodes continues unabated, but foundries are pushing full throttle just to stay afloat."
The above issues can and have negatively impacted semiconductor stocks of late, but industry c-suite types at least expected those headaches. But other threatening, and mostly unexpecting, threats have loomed large in early 2025 and have taken a swipe at sector share values.
These three semiconductor threats lead that list:
<h2 class="wp-block-heading">The dismantling of the CHIPS and Science Act</h2>
The Biden administration shepherded the CHIPS Act to a successful package and managed to get funds flowing to the chip sector, but the billions of dollars still on the table will likely be clawed back.
"When President Biden was leaving, you saw his administration push a lot of the CHIPS Act funds as quickly as they could because there was a lot of concern that the new administration would either slow it down or cancel it completely," Morales said. "So, companies like Intel (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) received a billion dollars in December and another, just over another billion dollars in January to map to the 7.8 billion that was earmarked for them."
Now, the US semiconductor industry, the primary beneficiaries of the CHIPS Act, is starting to see the Trump administration cutting back on National Institute of Science and Technology (NIST) employees, and that's stopped the flow of CHIPS funds to a trickle. "The NIST employees were vetting, managing, and issuing the funds to the companies that have already been awarded, and we&#8217;re starting to see some of that being dismantled now," Morales noted.
Another key CHIPS Act issue may even loom larger for semiconductor firms, as the Act's bylaws extended far beyond direct funding.
"People tend to look at the amount of money that&#8217;s been issued by the government, and they only see that," Morales said. "They don&#8217;t see the bigger investment profile, which is the fact that once these companies started working with the CHIPS Act, they also started getting tax incentives."
Those tax incentives are 25% on any type of manufacturing that semiconductor-related companies produce and deliver in the US. "These tax incentives were even more successful," Morales added "They drove over $200 billion worth of commitments by the semiconductor ecosystem as a whole."
<h2 class="wp-block-heading">The DeepSeek saga</h2>
China-based AI company DeepSeek threw the semiconductor industry – and the stock market – into panic mode with its January claim that company engineers had figured out how to produce stellar AI software models at a deeply discounted price. That news sidelined bigger name chip stocks for a week and left many more investors wondering if the Nvidia's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) of the world would take a big financial hit.
"DeepSeek put a dent in maybe the greatest AI success story of the last few years – especially Nvidia, which makes specialized semiconductor chips for AI inference and training," said Gimme Credit's Senior bond analyst Saurav Sen in an email to Benzinga.
Nvidia's seemingly insurmountable moat was challenged, perhaps ironically, as DeepSeek used Nvidia's older chips to train its models to be good enough not to need the latest-and-greatest Nvidia chips, Sen reported.
"The market ignored the irony by sending Nvidia's stock down about 20%, although it has recovered partially in the last month," he said. "The rough thesis was that everyone would emulate DeepSeek's efficient models, thereby reducing the need for advanced Nvidia GPUs and deflating Nvidia's baked-in and often lofty growth projections."
Other technology industry experts say that lower-cost AI solutions could pressure players like Nvidia. "However, at this point, the nature and design of those chips used by DeepSeek is not completely certain," said&nbsp; Dave Novosol, senior analyst at Gimme Credit. "Therefore, the extent of any competitive advantage versus Nvidia cannot be determined. Moreover, as the use of AI broadens and deepens, the chips produced by Nvidia may be necessary to meet the demands of future model builders."
The short-term impact on Nvidia is expected to be minimal because the dynamics of the AI arms race remain unchanged.
"Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), Meta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>), and Google (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) still believe more compute equals better models, that they will just be able to build better models than they originally projected with their planned hardware purchases," said Dev Nag, CEO/Founder at QueryPal, a former co-founder at Wavefront, and a former senior engineer at Google.
Nag said the tech sector is seeing a recalibration of expectations rather than a fundamental reduction in short-term demand. "Big tech understands that DeepSeek-style optimizations work multiplicatively with hardware advances, not as substitutes," he noted. "Architectural efficiency creates more value per GPU, but doesn&#8217;t diminish the incentive to buy more GPUs."
However, the longer-term picture gets murkier for Nvidia.&nbsp;
"If a small team can achieve breakthroughs while working with export-restricted chips, it suggests Nvidia&#8217;s moat might be more vulnerable than previously thought," Nag said. "Companies like AMD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>), Intel, and various AI ASIC startups will seize on these efficiency techniques to challenge Nvidia&#8217;s dominance."
The real threat to Nvidia isn&#8217;t that people will buy fewer chips overall but that customers might increasingly buy those chips from competitors with stronger price-performance ratios. "This gives potential Nvidia competitors renewed hope; they don&#8217;t need to match Nvidia&#8217;s raw performance to be viable alternatives if they can offer better price-performance through DeepSeek-style architectural innovations and software optimizations."
<h2 class="wp-block-heading">Tough Tariffs</h2>
New tariff policies targeting foreign semiconductor manufacturers, particularly those in China, are intended to drive reshoring efforts but also bring potential problems to the table.
"Tariffs also introduce risks such as higher production costs, supply chain disruptions, and potential retaliatory trade measures," said Kaveh Vahdat, founder and president of RiseOpp, a fractional CMO and SEO firm based in San Francisco. "For U.S.-based semiconductor firms, tariffs could create pricing pressures on raw materials and manufacturing equipment. For investors, key considerations include how companies can absorb increased costs or pass them on to customers without affecting demand."
<h2 class="wp-block-heading">The Takeaway on Semiconductor Sector Challenges</h2>
It's not just public policy and competition that vex semiconductor c-suites – structural changes are also challenging industry firms.
"Industry companies are also facing supply chain realignment," Vahdat said. "Companies are diversifying supply chains to reduce reliance on China, shifting production to Southeast Asia and India. This transition carries execution risks, cost implications, and time delays."
Talent shortages are also hindering sector performance. "The industry is facing a shortage of skilled labor, particularly in semiconductor fabrication and chip design," Vahdat added. "Workforce development will be a key determinant of manufacturing capacity."
Fundamental capital intensity issues add further uncertainty to the mix. "Expanding semiconductor production requires significant investment," Vahdat noted. "Companies must balance high upfront costs with uncertain demand cycles, especially amid potential economic slowdowns."
Semiconductor investors will have to balance the upside in AI, cloud computing, and data centers, among other sector home runs, with a growing number of challenges holding the semiconductor back.
Until those challenges are met head-on, sector share growth will likely continue to be muted, making 2025 a fascinating and complex year for the semiconductor industry and its army of increasingly nervous investors.
<a href="https://www.benzinga.com/premium/ideas/benzinga-edge/?el=ResearchDaily&amp;he={{email}}&amp;adt_ei={{email}}&amp;utm_adType=SponsorAd&amp;utm_ad=RD0303&amp;utm_campaign=wallstreetadvantage">Here&#8217;s What Wall Street&#8217;s Earnings Insiders See (That You&#8217;re Missing)</a>
Start trading earnings season like a pro – with real-time alerts the moment critical numbers drop. Plus, expert analysis that uncovers hidden opportunities in the post-earnings chaos. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge/?el=ResearchDaily&amp;he={{email}}&amp;adt_ei={{email}}&amp;utm_adType=SponsorAd&amp;utm_ad=RD0303&amp;utm_campaign=wallstreetadvantage">Get it all here.</a>
Image via Flickr

Opinion

GOOG

INTC

MSFT

NVDA

3 Reasons Why the Chip Stock Rally Is Over - For Now

A <a href="https://www.benzinga.com/etfs">unique new ETF</a> has debuted, offering investors an opportunity to align their financial goals with religious values — the JLens 500 Jewish Advocacy U.S. ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOV#NYSE">TOV</a>). Interestingly, the ticker symbol &#8220;TOV&#8221; translates as &#8220;good&#8221; in Hebrew.
With a net expense ratio of just 18 basis points, the ETF will mirror the performance of the JLens 500 Jewish Advocacy U.S. Index.
Developed by JLens, an affiliate of the Anti-Defamation League (ADL), the ETF not only seeks financial returns but also aims to hold corporations accountable for their policies and actions. TOV primarily follows a replication strategy to track its index but may occasionally use representative sampling at the discretion of fund advisors. 
While the index does not concentrate heavily on any single industry, as of Oct. 31, 2024, it had significant exposure to the information technology sector.
Also Read: <a href="https://www.benzinga.com/trading-ideas/25/02/43975122/matrix-asset-advisors-unveils-new-active-etf-for-value-driven-investors">Matrix Asset Advisors Unveils New Active ETF For Value-Driven Investors</a>
JLens excludes companies that derive more than 5% of their revenue from industries that conflict with Jewish ethical and social values, such as for-profit prisons, tobacco, oil sands production and thermal coal extraction.
Companies that make the cut are further evaluated based on three core Jewish advocacy principles, namely, combating antisemitism, supporting Israel and improving the world, which includes ethical business practices, labor rights, social responsibility and environmental concerns.
Each company is then assigned a value score, determining its weight in the index. As of Nov. 1, 2024, 496 companies, including major players like Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), Berkshire Hathaway Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>), and Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>), were included in the index.
<h1 class="wp-block-heading">Strong Backing From Jewish Organizations</h1>
The ETF <a href="https://www.businesswire.com/news/home/20250227623184/en/JLens-Launches-First-Ever-Jewish-Advocacy-ETF-TOV-on-NYSE-Backed-by-ADL-Foundation-and-Jewish-Organizations">launched </a>with over $100 million in seed capital from prominent Jewish organizations, including the ADL Foundation, the Atlanta Jewish Foundation, the Goodman Family Foundation and the Jewish United Fund of Metropolitan Chicago.
ADL data shows that the U.S. has recorded over 10,000 antisemitic incidents in the year following the October 7 attack. Additionally, JLens research found that more than 75 of the 500 largest U.S. companies were targeted by Boycott, Divest and Sanctions&nbsp;(BDS) campaigns in the past year, pressuring them to sever economic ties with Israel.
By combining financial performance with faith-based principles, TOV offers investors a unique way to make an impact while staying true to their values. With its launch, the Jewish community has a powerful tool to amplify its voice in corporate boardrooms and ensure that companies uphold ethical standards.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/etfs/sector-etfs/25/02/44050929/teslas-sharp-drop-sends-shockwaves-through-these-etfs">Tesla&#8217;s Sharp Drop Sends Shockwaves Through These ETFs</a></li>
</ul>
Photo: Shutterstock

Specialty ETFs

New ETFs

AAPL

GOOGL

JLens Launches TOV ETF, Merging Jewish Advocacy With Market Investing

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>William Blair analyst Andy Hsieh initiated coverage on Altimmune, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALT#NASDAQ">ALT</a>) with a Market Perform rating. Altimmune shares closed at $6.42 on Thursday. <a href="https://www.benzinga.com/quote/alt/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Craig-Hallum analyst Chase Knickerbocker initiated coverage on MediWound Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDWD#NASDAQ">MDWD</a>) with a Buy rating and announced a price target of $39. MediWound shares closed at $16.23 on Thursday. <a href="https://www.benzinga.com/quote/mdwd/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Deutsche Bank analyst Faiza Alwy initiated coverage on CoStar Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSGP#NASDAQ">CSGP</a>) with a Buy rating and announced a price target of $89. CoStar Group shares closed at $74.36 on Thursday. <a href="https://www.benzinga.com/quote/csgp/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Goldman Sachs analyst Salveen Richter initiated coverage on Summit Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMMT#NASDAQ">SMMT</a>) with a Buy rating and announced a price target of $42. Summit Therapeutics shares closed at $18.49 on Thursday. <a href="https://www.benzinga.com/quote/smmt/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Piper Sandler analyst Yasmeen Rahimi initiated coverage on Avalo Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVTX#NASDAQ">AVTX</a>) with an Overweight rating and announced a price target of $48. Avalo Therapeutics shares closed at $6.60 on Thursday. <a href="https://www.benzinga.com/quote/avtx/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/44018351/top-3-utilities-stocks-you-may-want-to-dump-in-february">Top 3 Utilities Stocks You May Want To Dump In February</a></li>
</ul>

Initiation

AVTX

CSGP

MDWD

SMMT

This CoStar Group Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Dillard's's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DDS#NYSE">DDS</a>) short percent of float has fallen 11.23% since its last report. The company recently reported that it has 809 thousand shares sold short, which is 27.03% of all regular shares that are available for trading. Based on its trading volume, it would take traders 7.48 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Dillard's Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740771038_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Dillard's has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Dillard's's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Dillard's's peer group average for short interest as a percentage of float is 9.49%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Is Dillard's Gaining or Losing Market Support?

AMETEK's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AME#NYSE">AME</a>) short percent of float has risen 13.54% since its last report. The company recently reported that it has 2.23 million shares sold short, which is 1.09% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.43 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>AMETEK Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740771032_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for AMETEK has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing AMETEK's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, AMETEK's peer group average for short interest as a percentage of float is 10.78%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Do Investors Really Feel About AMETEK?

XPeng's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) short percent of float has fallen 6.61% since its last report. The company recently reported that it has 32.99 million shares sold short, which is 4.38% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.85 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>XPeng Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740771026_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for XPeng has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing XPeng's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, XPeng's peer group average for short interest as a percentage of float is 9.47%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

XPEV

Is XPeng Gaining or Losing Market Support?

<a href="https://www.bloomberg.com/news/articles/2025-02-28/mexico-open-to-new-tariffs-on-china-to-avoid-trump-duties" title="https://www.bloomberg.com/news/articles/2025-02-28/mexico-open-to-new-tariffs-on-china-to-avoid-trump-duties">https://www.bloomberg.com/news/articles/2025-02-28/mexico-open-to-new-tariffs-on-china-to-avoid-trump-duties</a>

Macro Economic Events

Global

'Mexico Open To New Tariffs On China To Avoid Trump Duties; Mexico's Potential China Tariffs Would Focus On Cars And Auto Parts; Could Also Include Finished Goods' - Bloomberg News

Comments

General Copper Gold Short Interest Report

Short Interest

General Copper Gold Stock Short Interest Report | OTC:GNRGF | Benzinga

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga